Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07796451 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Low-Frequency rTMS for Sleep After Thoracoscopic Lung Resection

Study acronym: TMS-SLEEP-VATS
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Phase changed: Phase 2 → not applicable Show 7 more changesShow less
    • Start date pushed from Aug 31, 2026 to Oct 1, 2026
    • Study completion pushed from Sep 1, 2028 to Oct 1, 2028
    • Interventions modified
    • Eligibility criteria shortened, about 12 words
    • Secondary endpoints: 6 to 7
    • Study description shortened, about 105 words
    • Study title shortened, about 1 word
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This single-center randomized, double-blind, sham-controlled trial will evaluate whether low-frequency repetitive transcranial magnetic stimulation (rTMS) improves postoperative inpatient sleep in adults undergoing elective thoracoscopic lung resection for primary lung cancer. A total of 220 participants will be assigned 1:1 to active or matched sham stimulation. Five sessions will be delivered during seven perioperative calendar days, with no more than one session per day. The primary outcome is each participant's mean Richards-Campbell Sleep Questionnaire (RCSQ) total score across postoperative inpatient nights 1-3, calculated from at least two eligible nights. Secondary outcomes include length of postoperative hospitalization, pain, quality of life, actigraphy-derived sleep, anxiety, depression, electroencephalographic measures, and safety.
Trial Details
NCT Number NCT07796451
Lead Sponsor The First Affiliated Hospital of Guangzhou Medical University
Conditions
(from sponsor)		 Sleep Wake Disorders, Lung Neoplasms
Related terms Lung Neoplasms, Sleep Wake Disorders
Enrollment 220 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov